← Eichor
Study identifier: NCT01984762 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

Condition: Obesity · Type 2 Diabetes · Bariatric Surgery  ·  Sponsor: Göteborg University

PhaseNA
Planned participants134
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

Obesity is a growing epidemic throughout the world and is followed by increasing incidence of type 2 diabetes that accounts for 90-95% of all cases of diabetes. Weight loss is a major objective, although difficult to achieve with medical treatments. Many recent studies demonstrated that bariatric surgery has the potency to achieve marked and sustained weight loss, and is also associated with a significant improvement in control of type 2 diabetes. The principal aim of this study is to compare two types of bariatric procedures, the Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG). The study hypothesis is that these procedures have equal efficacy with regard to resolution of type 2 diabetes.

This description comes directly from the study's public registry record.

Talk to the study team

Ville R Wallenius, MD, PhD, Assoc Prof  ·  +46313428206  ·  ville.wallenius@gastro.gu.se

Almantas Maleckas  ·  +37068531143  ·  almantas_maleckas@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sahlgrenska University HospitalGothenburg, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01984762